Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebrun-Frenay

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Revue Neurologique|April 30, 2014
[Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions]C Lebrun-Frenay
Revue Neurologique|August 4, 2019
Infectious myelitisC Lebrun Frenay
Revue Neurologique|October 8, 2013
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments]C Lebrun-Frenay
Revue Neurologique|August 8, 2025
Discussing with our patient a presymptomatic adult-onset neurological diseaseC Lebrun-Frenay
Current Medical Research and Opinion|August 31, 2002
Choosing the right dopamine agonist for patients with Parkinson's diseaseC Lebrun-Frenay, M Borg
Revue Neurologique|November 7, 2017
Multiple sclerosis treatments and the anti-JCV antibody indexJ de Seze, C Lebrun-Frenay
Revue Neurologique|April 19, 2020
Covid-19, the pandemic war: Implication for neurologistsJ de Seze, C Lebrun-Frenay
Revue Neurologique|September 9, 2020
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis SocietyC Donzé, C Papeix, C Lebrun-Frenay, et al.
Revue Neurologique|August 8, 2025
Presymptomatic multiple sclerosis: Insights from the Radiologically Isolated SyndromeC Lebrun-Frenay, M Cohen, D T Okuda
Revue Neurologique|January 15, 2002
[Pain in multiple sclerosis]M Chatel, M Lantéri-Minet, C Lebrun-Frenay
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Revue Neurologique|April 30, 2014
[Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions]C Lebrun-Frenay
Revue Neurologique|August 4, 2019
Infectious myelitisC Lebrun Frenay
Revue Neurologique|October 8, 2013
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments]C Lebrun-Frenay
Revue Neurologique|August 8, 2025
Discussing with our patient a presymptomatic adult-onset neurological diseaseC Lebrun-Frenay
Current Medical Research and Opinion|August 31, 2002
Choosing the right dopamine agonist for patients with Parkinson's diseaseC Lebrun-Frenay, M Borg
Revue Neurologique|November 7, 2017
Multiple sclerosis treatments and the anti-JCV antibody indexJ de Seze, C Lebrun-Frenay
Revue Neurologique|April 19, 2020
Covid-19, the pandemic war: Implication for neurologistsJ de Seze, C Lebrun-Frenay
Revue Neurologique|September 9, 2020
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis SocietyC Donzé, C Papeix, C Lebrun-Frenay, et al.
Revue Neurologique|August 8, 2025
Presymptomatic multiple sclerosis: Insights from the Radiologically Isolated SyndromeC Lebrun-Frenay, M Cohen, D T Okuda
Revue Neurologique|January 15, 2002
[Pain in multiple sclerosis]M Chatel, M Lantéri-Minet, C Lebrun-Frenay
Pageof 4